# Zinc and Pneumonia Protocol

> **NCT00133432** · PHASE3 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 600 (—)

## Conditions studied

- Respiratory Infections, Acute

## Interventions

- **DRUG:** Zinc

## Key facts

- **NCT ID:** NCT00133432
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 600 (—)
- **Last updated:** 2019-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133432, "Zinc and Pneumonia Protocol". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00133432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*